LUMIBIRD announced the opening of its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost sales of Quantel Medical and Ellex products in India with a shared range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14 EUR | +0.36% | -1.41% | +14.94% |
Mar. 13 | Lumibird: EBITDA improved by 10% in 2023 | CF |
Mar. 12 | Lumibird SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.94% | 329M | |
+2.27% | 207B | |
+1.56% | 175B | |
+8.48% | 132B | |
+16.44% | 99.1B | |
-3.42% | 60.89B | |
+12.62% | 52.04B | |
-6.33% | 45.48B | |
-4.27% | 38.81B | |
+9.35% | 38.77B |
- Stock Market
- Equities
- LBIRD Stock
- News LUMIBIRD
- Lumibird Announces Opening of its New Indian Subsidiary in Mumbai: Lumibird Medical India